Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Fava

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Medicina (Kaunas, Lithuania)|June 19, 2019
Identification of Risk Factors for Multiple Non-Melanoma Skin Cancers in Italian Kidney Transplant RecipientsElisa Zavattaro, Paolo Fava, Federica Veronese, et al.
Anticancer Research|July 5, 2018
DNA from Human Polyomaviruses, MWPyV, HPyV6, HPyV7, HPyV9 and HPyV12 in Cutaneous T-cell LymphomasMassimiliano Bergallo, Valentina Daprà, Paolo Fava, et al.
Cancers|June 26, 2026
Neoadjuvant Therapy and the Evolving Management of Resectable Advanced MelanomaNikolaos Papadopoulos, Michele Del Vecchio, Andrea Spagnoletti, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 20, 2015
PCR Real time Mismatch Amplification Mutation Assay (MAMA Real Time PCR) for evaluation of TNF-α promoter gene polymorphism -308 G/A in patients with psoriasisMassimiliano Bergallo, Renata Ponti, Stefano Gambarino, et al.
Frontiers in Oncology|September 6, 2021
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future PerspectivesGabriele Roccuzzo, Silvia Giordano, Paolo Fava, et al.
American Journal of Clinical Pathology|December 17, 2014
Blood flow cytometry in Sézary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-upMauro Novelli, Paolo Fava, Cristina Sarda, et al.
Future Oncology (London, England)|September 11, 2018
BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete responseSimone Ribero, Ottavia Malavenda, Paolo Fava, et al.
Cancers|August 14, 2025
Dermoscopy of Melanoma According to Age Groups: A Retrospective Monocentric Study on 285 PatientsFrancesco Cavallo, Umberto Santaniello, Elisa Bin, et al.
Diseases (Basel, Switzerland)|June 25, 2025
Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer SyndromesChiara Anna Fiasconaro, Alice Carbone, Silvia Giordano, et al.
Cancer Reports (Hoboken, N.J.)|October 13, 2025
Synchronous Melanoma and Follicular Lymphoma in the Same Nodal Basin: A Diagnostic and Therapeutic ChallengeSilvia Borriello, Umberto Santaniello, Matteo G Brizio, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Medicina (Kaunas, Lithuania)|June 19, 2019
Identification of Risk Factors for Multiple Non-Melanoma Skin Cancers in Italian Kidney Transplant RecipientsElisa Zavattaro, Paolo Fava, Federica Veronese, et al.
Anticancer Research|July 5, 2018
DNA from Human Polyomaviruses, MWPyV, HPyV6, HPyV7, HPyV9 and HPyV12 in Cutaneous T-cell LymphomasMassimiliano Bergallo, Valentina Daprà, Paolo Fava, et al.
Cancers|June 26, 2026
Neoadjuvant Therapy and the Evolving Management of Resectable Advanced MelanomaNikolaos Papadopoulos, Michele Del Vecchio, Andrea Spagnoletti, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 20, 2015
PCR Real time Mismatch Amplification Mutation Assay (MAMA Real Time PCR) for evaluation of TNF-α promoter gene polymorphism -308 G/A in patients with psoriasisMassimiliano Bergallo, Renata Ponti, Stefano Gambarino, et al.
Frontiers in Oncology|September 6, 2021
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future PerspectivesGabriele Roccuzzo, Silvia Giordano, Paolo Fava, et al.
American Journal of Clinical Pathology|December 17, 2014
Blood flow cytometry in Sézary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-upMauro Novelli, Paolo Fava, Cristina Sarda, et al.
Future Oncology (London, England)|September 11, 2018
BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete responseSimone Ribero, Ottavia Malavenda, Paolo Fava, et al.
Cancers|August 14, 2025
Dermoscopy of Melanoma According to Age Groups: A Retrospective Monocentric Study on 285 PatientsFrancesco Cavallo, Umberto Santaniello, Elisa Bin, et al.
Diseases (Basel, Switzerland)|June 25, 2025
Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer SyndromesChiara Anna Fiasconaro, Alice Carbone, Silvia Giordano, et al.
Cancer Reports (Hoboken, N.J.)|October 13, 2025
Synchronous Melanoma and Follicular Lymphoma in the Same Nodal Basin: A Diagnostic and Therapeutic ChallengeSilvia Borriello, Umberto Santaniello, Matteo G Brizio, et al.
Pageof 8